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SARS-CoV-2 virus, the etiologic agent of COVID-19, has affected almost every aspect
of human life, precipitating stress-related pathology in vulnerable individuals. As the
prevalence rate of posttraumatic stress disorder in pandemic survivors exceeds that
of the general and special populations, the virus may predispose to this disorder by
directly interfering with the stress-processing pathways. The SARS-CoV-2 interactome
has identified several antigens that may disrupt the blood-brain-barrier by inducing
premature senescence in many cell types, including the cerebral endothelial cells. This
enables the stress molecules, including angiotensin II, endothelin-1 and plasminogen
activator inhibitor 1, to aberrantly activate the amygdala, hippocampus, and medial
prefrontal cortex, increasing the vulnerability to stress related disorders. This is
supported by observing the beneficial effects of angiotensin receptor blockers and
angiotensin converting enzyme inhibitors in both posttraumatic stress disorder and
SARS-CoV-2 critical illness. In this narrative review, we take a closer look at the virus-
host dialog and its impact on the renin-angiotensin system, mitochondrial fitness,
and brain-derived neurotrophic factor. We discuss the role of furin cleaving site, the
fibrinolytic system, and Sigma-1 receptor in the pathogenesis of psychological trauma.
In other words, learning from the virus, clarify the molecular underpinnings of stress
related disorders, and design better therapies for these conditions. In this context, we
emphasize new potential treatments, including furin and bromodomains inhibitors.
Keywords: PTSD, endothelia, SARS-CoV-2, COVID-19, mitochondria, lactate
Abbreviations: ANGII, angiotensin II; ET-1, endothelin-1; PAI-1, plasminogen activator inhibitor 1; RAS, renin-angiotensin
system; Sig-1R, Sigma-1 receptor; FCS, furin cleaving site;CECs, cerebral endothelial cells; ECs, endothelial cells, BDNF, brain
derived neurotrophic factor; MAVS, mitochondrial antiviral signaling; PTSD, posttraumatic stress disorder; SRDs, stress
related disorders; HPA, hypothalamic-pituitary axis; ARBs, angiotensin receptor blockers; ACEi, angiotensin converting
enzyme inhibitors; ACE-2, angiotensin converting enzyme 2; OXPHOS, oxidative phosphorylation; BRDs, bromodomains;
LTP, long term potentiation; LTD, long term depression; ASC1a, acid-sensitive ion channel-1a; TrkB, tropomyosin receptor
kinase B; AQP-4, aquaporin-4.
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GRAPHICAL ABSTRACT 1 | Covid-19 triggers endothelial cell (EC) senescence and dysfunction, likely predisposing to PTSD by increasing microvascular
permeability that enables the extravasation of stress molecules into the brain trauma-processing networks in amygdala, hippocampus and the medial prefrontal
cortex. The virus upregulates host angiotensin II (ANG II) (via S1 antigen), usurps furin/plasmin (via S2 antigen), mitochondria (via ORF9b), and Sigma-1 receptors
(Sig-1Rs) via NSP6. These structures, previously associated with PTSD, link the SARS-CoV-2 virus to increased susceptibility for stress related disorders. As ECs are
major producers of brain derived neurotrophic factor (BDNF), a neurotrophin altered in PTSD, senescent ECs lower this molecule further, predisposing to stress
related disorders.
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HIGHLIGHTS
- The SARS-CoV-2 virus triggers endothelial senescence by
usurping host serine proteases, the renin angiotensin system,
and mitochondria.
- Senescent endothelial cells disrupt the BBB tight junctions,
allowing stress molecules, including ANGc II, ET-1 and PAI-1,
access to the amygdala, hippocampus, and mPFC, increasing
the susceptibility for PTSD and other stress related disorders.
- Virus-damaged mitochondria predispose to PTSD by
shifting cellular metabolism from OXPHOS to glycolysis in
a Warburg effect.
- Virus-usurped furin and plasmin alter the pro-BDNF/ BDNF
ratio, predisposing to PTSD.
INTRODUCTION
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
the etiological agent of COVID-19, spread rapidly throughout
the world and was declared a pandemic in March 2020 (Wu and
McGoogan, 2020). Restrictive measures, including mandatory
isolation, social distancing, and absence of family support affected
fragile populations, including the psychiatric patients, more
than the society at large. In this group, many individuals
have experienced recurrence of depression, anxiety, and use of
substances, often culminating in posttraumatic stress disorder
(PTSD) (Chamberlain et al., 2021; Janiri et al., 2021). Moreover,
the experience of being hospitalized with COVID-19, facing
intubation, tracheostomy, and the possibility of death, amplified
the perception of life-threat, facilitating the development of
stress related disorders (SRDs) as well as depression and anxiety
(Dutheil et al., 2020; Tarsitani et al., 2021).
PTSD is a chronic debilitating syndrome that can
originate in vulnerable individuals after exposure to real
or threatened death, sexual assault, or severe illness.
Impaired fear extinction and excessive anxiety are believed
to drive the symptoms of this disorder (Myers and Davis,
2007). Clinical manifestations include re-experiencing the
traumatic event(s), hypervigilance, exaggerated startle reflex,
intrusive memories, nightmares, and dissociative phenomena
(Lancaster et al., 2016).
Although primarily treated by psychiatrists, PTSD may be
conceptualized as a systemic disease, considering its frequent
association with medical conditions, including metabolic,
autoimmune, and vascular disorders (Edmondson et al., 2013;
Yapici-Eser et al., 2021). In this regard, the comorbidity of
PTSD with cardiovascular and cerebrovascular disease, suggests
that dysfunctional endothelia may play a key role in the
pathophysiology of this disorder (Vaccarino et al., 2013; Chen
et al., 2015; Grenon et al., 2016).
In the general population, about 8% of trauma-exposed
individuals develop PTSD, while in military personnel and war
veterans, the PTSD prevalence can reach up to 16% (Gates
et al., 2012). Interestingly, some viral infections, including SARS-
CoV-2, human immunodeficiency virus (HIV) and Ebola were
associated with PTSD rates upward of 30%, indicating that these
pathogens may interact directly with microvessels and/or the
stress-processing centers of the brain (Lam et al., 2009; Siyahhan
Julnes et al., 2016; de Solis et al., 2017; Spottswood et al., 2017;
Kumar et al., 2021). Indeed, recent epidemiological data reported
a PTSD prevalence of up to 30.2% in COVID-19 survivors,
39.5% in Ebola and 34% in HIV, suggesting that these viruses
may directly target the cells of brain stress-processing pathways
(Israelski et al., 2007; Bah et al., 2020; Janiri et al., 2021). In
addition, as these pathogens contain a furin cleaving site (FCS),
PTSD may be precipitated by the viral exploitation of furin and
plasmin. These serine proteases were previously implicated in
SRDs as they convert a precursor protein, pro-BDNF, into brain
derived neurotrophic factor (BDNF) (Levin et al., 1997; Aksu
et al., 2018; Miranda et al., 2019).
Numerous studies have associated PTSD with the stress
mediators of the hypothalamic-pituitary-adrenal (HPA) axis and
autonomic nervous system, the two main drivers of stress related
phenotypes. However, here we only discuss the SARS-CoV-2-
usurped renin-angiotensin system (RAS) that can also trigger
this pathology (Chrousos and Zapanti, 2014; Griffin et al., 2014;
Marinzalda Mde et al., 2014; Terock et al., 2019; Yu et al., 2019;
Shkreli et al., 2020; Seligowski et al., 2021). Indeed, angiotensin
receptor blockers (ARBs) and angiotensin converting enzyme
inhibitors (ACEi) showed beneficial effects in both PTSD and
severe COVID-19, suggesting that dysfunctional RAS may play
an essential role in both conditions (Khoury et al., 2012; Marvar
et al., 2014; Vian et al., 2017). For instance, the SARS-CoV-
2 attachment to angiotensin converting enzyme 2 (ACE-2),
disrupts the blood-brain barrier (BBB) by inducing senescence
in cerebral endothelial cells ECs (Buzhdygan et al., 2020; Mehta
et al., 2021; Rhea et al., 2021; Sanchez-Vazquez et al., 2021).
This may enable ANG II to aberrantly activate its receptors in
the amygdala, hippocampus, and the medial prefrontal cortex
(mPFC), lowering the PTSD resilience (Marinzalda Mde et al.,
2014; Wang L. et al., 2016; Terock et al., 2019; Yu et al.,
2019; Shkreli et al., 2020). Increased BBB permeability facilitates
endothelin-1 (ET-1) and plasminogen activator inhibitor 1 (PAI-
1) extravasation and interaction with their respective receptors in
the stress-processing pathways, predisposing to PTSD (Kurihara
et al., 2000; Jiang et al., 2016; Chen et al., 2017a; Bouarab
et al., 2021). Moreover, as mitochondria express ANG II type
1 receptors (AT-1Rs), the virus may disrupt these organelles,
shifting metabolism, from oxidative phosphorylation (OXPHOS)
to glycolysis and lactate accumulation (Barron et al., 2004;
Doughan et al., 2008; Mellon et al., 2019; Sabbatinelli et al., 2019;
Gordon et al., 2020; Sher et al., 2020; Icard et al., 2021). It has been
established that lactate triggers flashbacks and panic attacks in
PTSD patients, suggesting that unchecked glycolysis may account
for the increased prevalence of SRDs in COVID-19 (Jensen et al.,
1997; Johnson et al., 2013).
In summary, the SARS-CoV-2 viral antigens may upregulate
ANG II, ET-1 and PAI-1, promoting mitochondrial dysfunction,
EC senescence and increased BBB permeability. Extravasation of
these stress-molecules into the brain parenchyma may reprogram
the amygdala, hippocampus and mPFC, predisposing to PTSD.
In our previous work, we discussed ANG II-mediated
mitochondrial dysfunction and premature EC senescence
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(Sfera et al., 2020, 2021a,b). Here, based on the SARS-
CoV-2 interactome, we go a step further, linking PTSD
vulnerability to virus-exploited furin, Sigma-1 receptors (Sig-
1Rs), plasmin, bromodomains and mitochondria, moving from
specific pathways to organelle structure. In other words,
attempting to learn from the virus, may clarify the SRDs
molecular underpinnings, and develop better therapies for
patients with PTSD. We also discuss potential new treatments,
including the inhibitors of furin and bromodomains.
STRESS, AGING VESSELS, AND THE
SARS-COV-2 VIRUS
SARS-CoV-2 is an enveloped, positive-sense single-stranded
RNA virus that ingresses human cells through several proteins,
including ACE-2 (Bourgonje et al., 2020; Hoffmann et al., 2020).
The virus consists a genome of about 29.9 kb, encoding for 29
structural, non-structural (NSP) and open-reading frame (ORF)
antigens that interact with numerous human proteins, triggering
pathological changes (Gordon et al., 2020). For example, virus-
upregulated ANG II interacts with AT-1Rs on cerebral ECs,
inducing premature senescence and increased BBB permeability
(Fleegal-DeMotta et al., 2009; Marinzalda Mde et al., 2014;
Marvar et al., 2014; Yu et al., 2019). A similar pathology is
triggered by viral interaction with mitochondria, bromodomain
4 (BRD4), furin, plasmin, and Sig-1Rs (Table 1; Kunieda et al.,
2006; Doughan et al., 2008; Gordon et al., 2020; Chamberlain
et al., 2021). The connection between FCS and PTSD, as well as
Sig-1Rs and PTSD are presented in detail below:
Furin Cleaving Site and PTSD
Novel studies reported premature endothelial senescence in
veterans and non-veterans with PTSD, indicating that BBB
disruption likely plays a pivotal role in this disorder (Boscarino,
2008; Grenon et al., 2016; Thurston et al., 2018). Others have
found that war veterans with PTSD, like older individuals, present
with defective mitochondria, telomeres, furin/plasmin, and
BDNF, connecting cerebral EC senescence with dysfunctional
subcellular structures (Levin et al., 1997; Doughan et al., 2008;
Gray and Ellis, 2008; Fleegal-DeMotta et al., 2009; Khoury et al.,
2012; Grenon et al., 2016; Aksu et al., 2018; Connolly et al., 2018;








S2 Furin/plasmin BDNF dysfunction Gray and Ellis (2008);
Gordon et al. (2020)
S1 ACE-2 Mitochondrial
dysfunction
Gordon et al. (2020);
Paris et al. (2020)
NSP6 Sigma-1 BDNF, Mitochondrial
dysfunction
Hashimoto (2015);
Gordon et al. (2020)
ORF9b TOM70 Mitochondrial
dysfunction
Gordon et al. (2020)
E BRD2/BRD4 Mitochondrial
dysfunction
Gordon et al. (2020);
Johnson et al. (2020)
Stein et al., 2018; Miranda et al., 2019; Seligowski et al., 2021;
Cleveland et al., 2021).
The SARS-CoV-2 antigen S1 usurps ACE-2, upregulating
ANG II, while S2 protein exploits furin and plasmin (Table 1).
Furin and plasmin are cell membrane serine proteases that
under normal circumstances promote the maturation of BDNF, a
neurotrophin involved in both PTSD and COVID-19 (Angelucci
et al., 2014; Miller et al., 2017; Azoulay et al., 2020). Viral S2
antigen activates the FCS, hijacking host furin and depleting
BDNF that in turn increases the risk of COVID-19 and SRDs
(Gray and Ellis, 2008; Johnson et al., 2020; Table 1). Indeed,
other viruses expressing FCS, including HIV and Ebola, were
associated with a high PTSD prevalence, linking this motif to
SRDs (Hallenberger et al., 1992; Volchkov et al., 1998; Figure 1).
There are also PTSD comorbidities observed with further viral
infections, however the scientific basis of those correlations
remains an active field of research (Papić et al., 2011; Coughlin,
2012; Morais-de-Jesus et al., 2014). Moreover, as furin and
plasmin regulate synaptic plasticity and the fibrinolytic system,
an impaired tissue-type plasminogen activator (tPA)/PAI-1 ratio,
may lower the resilience for both PTSD and COVID-19.
Indeed, severe COVID-19 and impaired fear extinction were
associated with tPA/PAI-1 dyshomeostasis (Bouarab et al., 2021;
Zuo et al., 2021).
Another peripheral molecule that alters BDNF maturation
is ET-1, a potent vasoconstrictor upregulated by ANG II (Lin
Y.J. et al., 2014; Chen et al., 2017b; Ward et al., 2018; Notaras
and van den Buuse, 2020; Diwakar et al., 2021). Since ET-1 was
directly corelated with PTSD, its exploitation by the SARS-CoV-2
virus (via ANG II) may also contribute to the high comorbidity
of PTSD and COVID-19 (Yammine et al., 2014; Fox et al.,
2018). Interestingly, ET-1 is synthesized as a biologically inactive
protein, proET-1, that requires processing by furin to convert
to bigET-1 and subsequently to ET-1 (Denault et al., 1995).
Along these lines, HIV, a FCS-containing virus, was associated
with upregulated ET-1, likely accounting for the high PTSD
comorbidity (Kanmogne et al., 2005; Neigh et al., 2016; Jain and
Mehrotra, 2020).
Taken together, dysfunctional subcellular components,
including furin/plasmin and BDNF, trigger cerebral EC
senescence and BBB disruption. The FCS motif of the SARS-
CoV-2 virus usurps human furin and plasmin, altering BDNF
homeostasis that in turn predispose to SRDs (Kanmogne et al.,
2005; Figure 1).
Sigma-1receptors and PTSD
The SARS-CoV-2 antigen NSP6 exploits host Sig-1R, a positive
BDNF regulator, likely disrupting synaptic plasticity and
predisposing to SRDs (Fujimoto et al., 2012; Hashimoto, 2015,
2021; Xu et al., 2015; Gordon et al., 2020; Figure 1). In addition,
as ECs are major sources of BDNF and senescent ECs are depleted
of this neurotrophin, the susceptibility for both COVID-19 and
PTSD is likely increased (Nakahashi et al., 2000; Descamps et al.,
2018; Marie et al., 2018; Table 1).
Under physiological circumstances, Sig-1Rs agonists
upregulate BDNF, protecting against EC damage triggered
by either psychological stress and possibly the SARS-CoV-2 virus
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FIGURE 1 | Several SARS-CoV-2 antigens interact directly with host EC proteins, inducing cellular senescence and altering the BBB permeability. Viral hijacking of
furin/plasmin by antigen S2 impairs BDNF maturation, increasing PTSD susceptibility. The S1/ACE-2 attachment upregulates ANG II, inducing mitochondrial damage
and cellular senescence. Viral ORF9b disrupts mitochondria directly, altering antiviral defenses and cellular metabolism. The SARS-CoV-2 antigen E exploits host
epigenetic readers BRD-2 and BRD-4, altering the expression of mitochondrial proteins encoded in the nuclear DNA. Viral antigen NSP6 interacts with Sigma-1
receptors, inducing cellular senescence by an alternative pathway.
(Kimura et al., 2013). In addition, activated Sig-1Rs increase
mitochondrial pregnenolone, protecting the organelle from
psychological stress and virus-mediated dysfunction (Marriott
et al., 2012) (see the section on mitochondria and neurosteroids).
Indeed, the Sig-1Rs agonist, fluvoxamine, was shown to lower the
intensity of stressful memories in SRD patients and to ameliorate
COVID-19 outcomes (De Boer et al., 1992; Escalona et al., 2002;
Pal et al., 2012; Hashimoto, 2013, 2021; Ji et al., 2017; Inserra,
2018; Sukhatme et al., 2021). Moreover, Sig-1R activating drugs
were reported to protect against ANG II-induced EC damage,
suggesting that combining ARBs/ACEi with Sig-1R agonists
could have a superior therapeutic value in both COVID-19
and PTSD (Meunier and Hayashi, 2010; Hirano et al., 2014;
Natsvlishvili et al., 2015; Liu et al., 2018; Lewis et al., 2019).
Furthermore, virus-upregulated ANG II and hijacked Sig-1Rs
may explain the early development of neurodegeneration
observed in many PTSD patients (Yaffe et al., 2010; Mohlenhoff
et al., 2017; Sobczak et al., 2021).
In response to stressors, cells undergo senescence, a state
of proliferation arrest and active metabolism fueled primarily
by glycolysis-derived lactate (Wiley and Campisi, 2016).
Interestingly, under normal circumstances, ECs obtain over 80%
of adenosine triphosphate (ATP) from lactate despite oxygen
availability (Warburg effect), probably explaining the SARS-
CoV-2 predilection for these cells (Sabbatinelli et al., 2019; Leung
and Shi, 2021). Indeed, as senescent ECs upregulate lactate even
more than their younger counterparts, they engender an optimal
environment for viral replication (Schmid et al., 2007; Wong
et al., 2017). Upon crossing into the brain parenchyma, lactate
generates a local acidic microenvironment that may activate
the acid-sensing ion channel-1a (ASIC1a), a protein implicated
in SRDs (Coryell et al., 2009; Ziemann et al., 2009; Smoller
et al., 2014; Quagliato et al., 2018). For example, low brain pH
activates amiloride-sensitive cation channel, an member of the
ASIC1a family, triggering PTSD symptoms (Taugher et al., 2017;
Quagliato et al., 2018). Indeed, lactate was demonstrated to
precipitate flashbacks and anxiety in PTSD and panic disorder
patients, connecting unchecked glycolysis to the high prevalence
of SRDs in COVID-19 survivors (Jensen et al., 1997; Filipović
et al., 2020). Indeed, ASIC1a receptor antagonist, amiloride, was
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reported beneficial in anxiety and SRDs, further implicating
glycolysis in these conditions (Pidoplichko et al., 2014; Battaglia
et al., 2019). For this reason, amiloride nasal spray is considered
therapeutic for PTSD as it readily crosses the BBB, inhibiting
ASIC1a (Dwyer et al., 2009; Yellepeddi et al., 2020). Interestingly,
under physiological circumstances, Sig-1R agonists also inhibit
ASIC1a, indicating that drugs like fluvoxamine may counteract
the detrimental effects of excessive brain lactate (Herrera et al.,
2008). In consequence, a combination of fluvoxamine and
amiloride may be a superior PTSD therapy compared to each
drug individually.
Hijacking Sig-1Rs, the SARS-CoV-2 virus likely increases the
detrimental effects of lactate on brain stress-processing pathways,
explaining the high prevalence of SRDs in this infection (Vela,
2020; Figure 1). Moreover, ASIC1a receptors are abundantly
expressed in cerebral arteries, suggesting that, like ANG II,
upregulated lactate may increase the BBB permeability (Lin L.H.
et al., 2014). This is in line with preclinical studies showing that
lactate operates hand in hand with ANG II to engender anxiety
(Shekhar et al., 2006; Yu et al., 2019).
Taken together, Sig-1R agonists, such as fluvoxamine, may
reverse the negative effects of virus-upregulated ANG II on
endothelia. As Sig-1R are downregulated by psychological and
cellular stress, agonists at these receptors in combination with
ARBs, ACEi or amiloride may offer superior therapeutic efficacy
to patients with PTSD and severe SARS-CoV-2 (Spottswood et al.,
2017; Hashimoto, 2021; Janiri et al., 2021).
THE SARS-COV-2 VIRUS,
PSYCHOLOGICAL STRESS, BDNF AND
THE FIBRINOLYTIC SYSTEM
Beyond the direct interaction of SARS-CoV-2 proteins with
specific pathways in the interactome, the following paragraphs
take a wider, more systematic perspective, focusing on
psychological stress and BDNF as well as the fibrinolytic system.
The Virus and BDNF
Brain derived neurotrophic factor is a growth factor belonging
to the neurotrophin family that promotes angiogenesis,
neurogenesis, and synaptic plasticity, enhancing the CNS
recovery after insults (Alhusban et al., 2016). BDNF is
synthesized as a biologically inactive precursor protein,
pro-BDNF, that is activated upon furin or plasmin processing
(Luchkina and Bolshakov, 2019).
Brain derived neurotrophic factor signals with tropomyosin
receptor kinase B (TrkB), promoting hippocampal long-term
potentiation (LTP), synaptic plasticity and memory formation
(Jia et al., 2010; Leal et al., 2015). In contrast, pro-BDNF activates
p75 neurotrophin receptor (p75NTR), inducing hippocampal
long-term depression (LTD), dysfunctional synaptic plasticity
and likely impaired fear learning (Rösch et al., 2005; Martinowich
et al., 2012). Indeed, PTSD was associated with LTD, defective
fear extinction, and impaired memory, likely accounting for
the hypermnesia and dissociative amnesia documented in these
patients (Graves et al., 2016; He et al., 2018).
In the adult brain, p75NTR is expressed almost exclusively in
the cholinergic neurons of the basal forebrain and is altered by
psychological stress, connecting neurotrophins to acetylcholine
signaling (Woo et al., 2005; Martinowich et al., 2012; Green
et al., 2013; Aksu et al., 2018; Boskovic et al., 2018; Ilchibaeva
et al., 2018). Along these lines, neuroimaging studies in PTSD
patients found abnormal activation of basal forebrain cholinergic
neurons, suggesting that p75NTR may be upregulated (Hughes
and Shin, 2011; Sherin and Nemeroff, 2011; Turchi et al.,
2018). In addition, the adverse effects of acetylcholinesterase
inhibitors often resemble PTSD symptoms, indicating that
hyperactive cholinergic signaling may play a role in SRDs (Kaufer
et al., 1998; McLay and Ho, 2007). Indeed, preclinical studies
associated PTSD with dysfunctional p75NTR in basal forebrain
(Martinowich et al., 2012). This is in line with the clinical studies
in combat veterans with PTSD and non-veterans with anxiety
and aggression that documented abnormal pro-BDNF/BDNF
ratio, likely due to p75NTR upregulation (Matsuoka et al., 2015;
Ilchibaeva et al., 2018; Kowiański et al., 2018).
Despite the established connection between BDNF and PTSD,
the neurotrophin serum levels have been inconclusive, indicating
that more studies are needed to clarify this issue (Angelucci
et al., 2014; Martinotti et al., 2015; Mojtabavi et al., 2020). For
example, low BDNF was found in individuals that developed
PTSD shortly after stress exposure, while others found increased
BDNF levels in patients with established PTSD (Angelucci
et al., 2014; Mojtabavi et al., 2020). This discrepancy might
be reconciled if BDNF is considered together with nitric oxide
(NO) and peroxinitrate levels (Biojone et al., 2015; Banoujaafar
et al., 2016). While NO itself lowers BDNF, peroxynitrate
was shown to upregulate astrocytic growth factors, probably
including the BDNF (Canossa et al., 2002; Vargas et al., 2004).
Psychological stress was associated with the overexpression of
nitric oxide synthase and peroxynitrate upregulation, linking
oxidative stress with psychosocial trauma (Kumar and Chanana,
2017). On the other hand, NO has antioxidant properties and
was reported to decrease anxiety and depressive-like behaviors
in animal models (Kumar and Chanana, 2017). Interestingly,
peroxynitrate is a TrkB receptor agonist that may compete with
BDNF for the receptor site, accounting for the elevated BDNF
levels documented in patients with chronic PTSD (Yuen et al.,
2000; Amoureux et al., 2008; Krolow et al., 2014). Moreover,
ebselen, a peroxynitrate scavenger, was found therapeutic in
COVID-19, probably by restoring the physiologic BDNF/TrkB
signaling, indicating a potential therapeutic value in PTSD (Chen
et al., 2007; Amporndanai et al., 2021). Along these lines,
several studies found that NO inhibitors, including methylene
blue, can lower anxiety and depression, ameliorating many
SRD symptoms (Chen et al., 2007; Zoellner et al., 2017).
Furthermore, a polymorphism of NO gene, nitric oxide synthase
1 adaptor protein (NOS1AP) and a BDNF variant, Val66Met,
were associated with severe PTSD, emphasizing the importance
of NO/BDNF dialog in this disorder (Chen et al., 2006; Bruenig
et al., 2017; Pitts et al., 2019). Indeed, a dysfunctional NO/BDNF
interaction with resultant EC senescence, was found in both
PTSD and COVID-19 critical illness (Azoulay et al., 2020; Nehme
et al., 2020). Interestingly, NO is a furin inhibitor that may lower
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SARS-CoV-2 infectivity by denying this serine protease to the
virus (Wolf and Morrison, 2017). For this reason, NO is currently
in clinical trials for COVID-19 (NCT04388683).
Other furin inhibitors, including diminazene, are currently
being evaluated for efficacy against COVID-19, suggesting that
withholding furin from the SARS-CoV-2 virus may comprise a
valuable therapeutic strategy (AbdelMassih et al., 2020; Wu et al.,
2020). As diminazene also blocks ASIC1a channels, attenuating
the detrimental effect of brain lactate, this agent may also be
therapeutic in PTSD (Qaradakhi et al., 2020). Furthermore,
spironolactone, another furin inhibitor, was found to protect
against COVID-19 critical illness, suggesting a potential role in
PTSD (Schmidt et al., 2017).
Aside from neurons, BDNF also protects ECs and type
II pneumocytes (both cell types targeted by SARS-CoV-2),
emphasizing that this neurotrophin likely attenuates viral
replication (Takeda et al., 2013; Wilcox and Pitt, 2020). Indeed,
COVID-19 critical illness was associated with low BDNF, while
recovery was directly corelated with the levels of this growth
factor (Azoulay et al., 2020). Moreover, as ACE-2 is essential
for BDNF release, viral exploitation of this protein, likely
impairs synaptic plasticity, predisposing to SRDs (Paris et al.,
2020). On the other hand, ARBs and ACEi were shown to
upregulate BDNF, improving synaptic plasticity, further linking
dysfunctional RAS to PTSD (Ishrat et al., 2015; Alhusban et al.,
2016; Andhavarapu et al., 2021; Table 2).
The Virus and Fibrinolytic System
The fibrinolytic system regulates thrombolysis (via plasmin
activation) and neuroplasticity (via BDNF) (Wang X.L. et al.,
2016). Both severe COVID-19 and PTSD were associated with
upregulated PAI-1, a negative tPA regulator, indicating that
targeting this protein may be therapeutic for both diseases (Cesari
et al., 2010; Idell et al., 2017; Bouarab et al., 2021). Indeed, PAI-
1 has been identified as a potential target in COVID-19 and
its antagonists, such as statins, are currently in clinical trials
(NCT04634799) (NCT04472611) (Bouarab et al., 2021; Kellici
et al., 2021; Figure 2).
COVID-19-induced endothelial senescence and altered BBB
may facilitate PAI-1 extravasation and interference with the
stress-processing centers in amygdala, hippocampus, and mPFC.
Several studies connected tPA/PAI-1 imbalance to PTSD, fear,
anxiety, and depression, suggesting that restoring the fibrinolytic
homeostasis may ameliorate the symptoms of SRDs (Pawlak
et al., 2003; Bouarab et al., 2021). In addition, senescent ECs
upregulate PAI-1, disrupting both plasmin activation and BDNF
maturation, predisposing to PTSD (Pawlak et al., 2003; Tsai, 2017;
Vaughan et al., 2017; Figure 2). On the other hand, ARBs and
ACEi upregulate plasmin and downregulate PAI-1, promoting
BDNF maturation and synaptic plasticity (Fogari and Zoppi,
2006; Baluta and Vintila, 2015; Chen et al., 2017c).
Attempts to increase BDNF levels with exogenous
neurotrophin have been frustrating because of the unfavorable
pharmacodynamic properties of this molecule, including poor
BBB crossing. For this reason, a new modality, BDNF delivery
via minimally invasive nasal depot (MIND), appears to be a
promising PTSD treatment (Szekeres et al., 2010). In addition,
TABLE 2 | Drugs with potential benefit in PTSD and mechanism of action.
Drug Action mechanism References
Amiloride ASIC1a antagonist Pidoplichko et al. (2014);
Battaglia et al. (2019)





Fogari and Zoppi (2006);
Matsushita et al. (2010);
Dikalov and Nazarewicz (2013);
Baluta and Vintila (2015);
Ishrat et al. (2015);
Chen et al. (2017c);




Chen et al. (2007);
Amporndanai et al. (2021)
NO Furin inhibitor Wolf and Morrison (2017)
Diminazene Furin inhibitor, ASIC1a
antagonist
Qaradakhi et al. (2020)
Spironolactone Furin inhibitor Schmidt et al. (2017)
Statins PAI-1 inhibitors Kellici et al. (2021)
BDNF (via MIND) TrkB agonist Padmakumar et al. (2021)
7,8-
dihydroxyflavone
TrkB agonist Sanz-García et al. (2016)
Lithium TrkB agonist Forster et al. (1995)
LM22A-4 TrkB agonist Forster et al. (1995)
Fluoxetine AQP-4 upregulation Di Benedetto et al. (2016)
SS-31 Mitochondrial
antioxidant
Tarantini et al. (2018)
Propranolol Glycolysis inhibitor Vaiva et al. (2003);





Kho et al. (2019)
Brexanolone Mitochondrial and BBB
protector
Pineles et al. (2018);
Morrison et al. (2019)
Progesterone NO upregulation? Balan et al. (2019);
Ney et al. (2019)
JQ1/SF2523 Senolytics, BRD
inhibitors
Go et al. (2021)
Trauma-focused
psychotherapy
T-cell enhancer Morath et al. (2014)
several TrkB receptor agonists have been tested in veterans with
PTSD, including the small molecule, 7,8-dihydroxyflavone, that
showed beneficial effects in many patients (Padmakumar et al.,
2021). In addition, as lithium displays TrkB agonism, it was
found helpful, especially for the PTSD patients with impulsivity
and affective instability (Sanz-García et al., 2016). Another
TrkB agonist, LM22A-4, has been suggested for use in PTSD
as it showed some positive results in animal models (Forster
et al., 1995). Interestingly, candesartan was demonstrated to
upregulate BDNF and promote angiogenesis, suggesting a
potential treatment for dysfunctional endothelia and PTSD
(Andero and Ressler, 2012; Table 2).
Taken together, psychological stress causes overexpression of
nitric oxide synthase and peroxynitrate formation, disrupting
the pro-BDNF/BDNF balance. Peroxynitrate scavengers
and TrkB agonists, including intranasal BDNF, may have
therapeutic value in SRDs.
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FIGURE 2 | Under normal circumstances, tPA facilitates conversion of plasminogen to plasmin. PAI-1 is a tPA inhibitor that downregulates plasmin, a protein
necessary for BDNF maturation. The SARS-CoV-2 interaction with ACE-2, increases ANG II inducing EC senescence. Senescent ECs upregulate PAI-1, lowering tPA
and plasmin levels. SARS-CoV-2 antigen S2 usurps furin and plasmin (not shown), disrupting the conversion of pro-BDNF into BDNF, that in return impairs synaptic
plasticity, predisposing to PTSD. Upregulated pro-BDNF increases PTSD vulnerability further.
OF STRESS AND WATER
Cerebral ECs form the BBB with astrocytic end-feet, structures
rich in aquaporin-4 (AQP-4) channels that also engender the
glymphatic system, a waste disposal apparatus, located between
astrocytic processes and ECs (Daneman and Prat, 2015; Krikov
et al., 2008). Interstitial fluid (ISF) circulation through this space
facilitates the clearance of molecular debris and contributes to the
brain-wide diffusion of peptides, neurotransmitters, BDNF and
viral particles (Jessen et al., 2015; Plog and Nedergaard, 2018;
Figure 3). A growing body of evidence connected that AQP-
4 to BDNF and neuroplasticity in the hippocampus, amygdala
and mPFC (Szu and Binder, 2016; Huber et al., 2018). On
the other hand, dysfunctional AQP-4 channels were associated
with depression, insomnia, dysfunctional synaptic plasticity, and
impaired fear extinction (Scharfman and Binder, 2013; Berntsen
and Rubin, 2014). For example, AQP-4 knockout mice displayed
both corticosterone-induced depression and defective memory,
symptoms reversed by mifepristone and fluoxetine, linking the
brain water circulation to SRDs (Kong et al., 2014; Di Benedetto
et al., 2016). Moreover, astrocytic end-feet were demonstrated
to contain abundant angiotensinogen, a molecule regulated by
AQP-4, connecting this protein to RAS (Wei et al., 2019).
Interestingly, ARBs and ACEi were demonstrated to upregulate
peritoneal AQP-4, suggesting that these agents may have a similar
effect in astrocytic end-feet (Matsushita et al., 2010). In addition,
as COVID-19 was reported to target hippocampal astrocytes,
the virus likely alters AQP-4 (via ANG II), disrupting synaptic
plasticity and fear extinction (Imai et al., 2001; Tavčar et al., 2021).
In our previous work on delirium, we hypothesized that
dysfunctional AQP-4, led to impaired information processing,
connecting these proteins to neuroplasticity and memory
formation (Sfera et al., 2015; Ritchie et al., 2020). This is
now supported by data, demonstrating that AQP-4 receptors
are essential for brain activation during mental work and
deactivation during downtime or sleep, revealing an inverse
relationship between memory formation and ISF circulation
(Sfera and Osorio, 2014; DiNuzzo and Nedergaard, 2017).
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FIGURE 3 | During brain activation and information processing, ISF enters active astrocytes via AQP-4 channels, leaving less fluid in the extracellular space and
upregulating lactate (shuttled to neurons). During idle time or slow wave sleep, ISF exits the astrocyte, widening the extracellular space and lowering lactate to
facilitate waste clearance. To accomplish their physiological functions, astrocytes require activation by BDNF. Senescent cerebral ECs produce less BDNF, probably
leading to astrocyte deactivation and dysfunctional glymphatic clearance.
Indeed, astrocytic end feet, express the most AQP-4 channels
in the entire CNS, playing a key role in brain activation and
deactivation (Mader and Brimberg, 2019).
Astrocytes have previously been implicated in PTSD as they
regulate synaptic transmission, plasticity, and the formation
of aversive memories (Nagelhus and Ottersen, 2013; Saur
et al., 2016). To participate in neuroplasticity as well as in
the glymphatic circulation, astrocytes require activation by
BDNF (Brigadski and Leßmann, 2020). In this regard, PTSD-
associated hypermnesia and dissociative amnesia may be traced
to astrocytic deactivation (Kol et al., 2020). For example,
preclinical studies have associated fear with dysfunctional
glymphatic circulation, further connecting the astrocyte to
stressful experiences (Li et al., 2020). As astrocytic activation
restores the glymphatic circulation, lowering anxiety and fear
in animal models, stimulation of these cells may emerge
as a therapeutic strategy for SRDs (Martin-Fernandez et al.,
2017; Verkhratsky and Nedergaard, 2018; Figure 3). Other
preclinical studies have reported that ANG II inhibits GABAergic
transmission in the CNS, triggering anxiety and fear, further
connecting dysfunctional RAS to SRDs (Li and Pan, 2005; Wang
et al., 2018; Zhou et al., 2019). This is significant as it may explain
the high prevalence of PTSD in COVID-19 survivors.
Astrocytes have been reported to drive LTP as they shuttle
lactate to active neurons, increasing plasticity and memory
formation (Hagiwara and Kubo, 2007). Indeed, preclinical
studies have associated amnesia with impaired astrocytic lactate
transporters, while studies in humans linked psychological stress
to the upregulated plasma lactate (Suzuki et al., 2011; Descalzi
et al., 2019). Moreover, patients with neuromyelitis optica, a rare
autoimmune disease marked by autoantibodies against AQP-
4, demonstrated elevated lactate concentrations, suggesting an
inverse relationship between glycolysis and the expression of
water channels in astrocytic end-feet (Kubera et al., 2012). Along
these lines, novel studies have shown that lactate circulates
through AQP-4 and that glycolysis is inversely corelated with the
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expression of water channels (Jarius et al., 2014). Indeed, lactate is
upregulated during brain activation, likely to facilitate water entry
into astrocytes, while during idle time or slow wave sleep, AQP-4
channels are downregulated to facilitate the glymphatic clearance
(Jarius et al., 2014).
Several viruses, including HIV and SARS-CoV-2, were
associated with AQP-4 autoantibodies, suggesting that disabling
the water channels to upregulate lactate may be a strategy adopted
by select pathogens (Lundgaard et al., 2017; Rahimy et al., 2017;
Mariajoseph-Antony et al., 2020; Tice et al., 2020; Erickson et al.,
2021). Indeed, AQP-4 autoantibodies were found in a subset
of COVID-19 patients with neurological symptoms, linking
defective water channels to COVID-19 critical illness (Corrêa
et al., 2021). In contrast, normal aging was associated with
upregulated AQP-4 and loss of glycolysis, further emphasizing
the inverse relationship between water channels and brain lactate
(Owasil et al., 2020; Corrêa et al., 2021).
Taken together, dysfunctional AQP-4 interferes with RAS
and the brain metabolism. As viruses thrive in lactate-rich
environments, they may have developed the capability to disable
AQP-4 channels, promoting glycolysis and excessive lactate that
increases SRD vulnerability.
MITOCHONDRIA AND PTSD
As the final part of the manuscript, we are looking into the higher
cellular structures, i.e., organelles and in particular mitochondria,
their relation to COVID-19, and potential insights into PTSD.
Mitochondria are dynamic intracellular organelles that
participate in multiple physiological functions, including
metabolism, ROS generation, cellular senescence, and innate
antiviral immunity (Goyal et al., 2017). The latter is initiated
by mitochondrial import of antiviral signaling protein (MAVS)
through the pore TOM70 (translocase of the outer mitochondrial
membrane 70) (Seth et al., 2005; Tang et al., 2014; Gordon et al.,
2020). Indeed, most of the mitochondrial proteome is encoded by
the nuclear genome and imported into the organelle as precursor
proteins. Recently, TOM70 was associated with mitochondrial
bioenergetics, indicating that viral exploitation of this protein
could also alter cellular metabolism (Liu et al., 2010; Figure 4).
Mitochondria are rich in iron as they house the iron-sulfur
clusters (ISCs) and heme prosthetic groups. Since infectious
agents, including the SARS-CoV-2 virus may require iron for
replication, they target the mitochondrion. However, the host
immune system is also dependent on iron for clonal expansion
and sequestrates this biometal, initiating the “battle for iron”
(Filadi et al., 2018). To extract iron, the SARS-CoV-2 virus may
damage the mitochondrion directly via ORF9b and indirectly
via bromodomains and ANG II (Gordon et al., 2020; Figure 1).
As mitochondria express AT-1R and ET-1Rs, the virus may also
disrupt the organelle via ANG II accumulation (Carver, 2018;
Ganji and Reddy, 2021). For example, ANG II-upregulated ET-1
damages the organelle by interfering with mitochondrial genome
and the cellular metabolism (Dikalov and Nazarewicz, 2013).
Indeed, several studies found that ROS upregulate mitochondrial
FIGURE 4 | Glycolysis takes place in the cytoplasm where glucose is
converted to pyruvate. Under normal circumstances pyruvate enters the
mitochondrion and generates ATP via OXPHOS. Damaged mitochondria may
be incapable of sustaining OXPHOS, forcing the cell to rely on lactate
(generated via LDH). Excess lactate blocks the antiviral MAVS entry into the
mitochondrion through the TOM70 pore. SARS-CoV-2 virus targets TOM70
(via ORF-9b), emphasizing the importance of this channel for both antiviral
defenses and cellular metabolism.
AT-1Rs, while ARBs or ACEi lower ROS, restoring mitochondrial
function (de Cavanagh et al., 2003; Chaphalkar et al., 2020).
Psychological stress was shown to upregulate ROS, damaging
the mitochondrion that in turn triggers cellular senescence
in many cell types, including the cerebral ECs (Dai et al.,
2011; Toda and Nakanishi-Toda, 2011; Salim, 2014; Kershaw
et al., 2017). On the other hand, preclinical studies have
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 October 2021 | Volume 15 | Article 770387
fncel-15-770387 October 28, 2021 Time: 12:36 # 11
Sfera et al. COVID-19, PTSD, BBB
reported that mitochondrial antioxidants, such as elamipretide
or SS-31, restore organelles’ homeostasis, restoring endothelial
function (Tarantini et al., 2018; Chiao et al., 2020). Along
these lines, several studies on combat veterans with PTSD
found a direct relationship between symptom severity and the
degree of mitochondrial damage, emphasizing the role of these
organelles in SRDs (Flaquer et al., 2015; Bersani et al., 2016;
Chen et al., 2017d). Moreover, psychological stress-upregulated
ROS trigger telomere attrition, a phenomenon encountered in
both PTSD and severe COVID-19, linking these conditions
to premature aging (Atanackovic et al., 2002; Yegorov et al.,
2020). Interestingly, it was reported that aside from AT-1Rs
and ET-1Rs, mitochondria also expressed gamma-aminobutyric
acid (GABA), glucocorticoid, and monoamine oxidase A and B
receptors, further connecting the organelle to SRDs (Krueger,
1995; Mongelli et al., 2021).
Mitochondria and Lactate
Most cells throughout the body obtain ATP from mitochondria-
associated OXPHOS but under hypoxic conditions switch to
glycolysis, deriving energy from lactate (Naoi et al., 2006; Owasil
et al., 2020). The SARS-CoV-2 virus may target mitochondria to
acquire iron and block the import of MAVS, while at the same
time it rewires the cellular metabolism to aerobic glycolysis in
a Warburg-like effect encountered in malignant cells (Wilson,
2017; Figure 4). Damaged organelles release mitochondrial
DNA (mDNA), including copy number (mtDNAcn) and cell-
free mitochondrial DNA (cf-mtDNA), emphasizing potential
biomarkers for both PTSD and COVID-19 critical illness
(Bersani et al., 2016; Chauhan et al., 2019; Scozzi et al., 2021;
Trumpff et al., 2021).
As the SARS-CoV-2 virus thrives on lactate, it preferentially
targets ECs, that under normal circumstances, derive most of
their energy from glycolysis. In addition, as the virus induces
EC senescence, it may upregulates lactate further, generating a
friendly microenvironment for its replication. Excessive brain
lactate, as discussed above, likely triggers PTSD symptoms by
activating ASIC1a and downregulating AQP-4 (Smoller et al.,
2014; Quagliato et al., 2018; Li et al., 2020).
Propranolol, an established glycolysis inhibitor, has been
utilized in PTSD for decades as it facilitates the extinction of
fear learning, linking this cognitive defect to excessive lactate
(Vaiva et al., 2003; Brohée et al., 2018; Ganji and Reddy, 2021).
In addition, propranolol protects ECs by restoring mitochondrial
integrity, increasing PTSD resilience (Giustino et al., 2016).
Propranolol also blocks the Warburg effect, disrupting the
energy supply of both malignant and virus-infected cells,
emphasizing the anticancer and antiviral properties of this drug
(Iwai et al., 2002; Lucido et al., 2018; Barbieri et al., 2020;
Vasanthakumar, 2020).
Aside from its role as a metabolite, lactate is also a signaling
molecule that interacts with G-protein-coupled receptor 81
(GPR81), increasing angiogenesis and opposing ECs senescence
(Morland et al., 2015, 2017). Interestingly, preclinical studies
reported that GPR81 agonists trigger anxiety via cAMP,
suggesting that blocking these receptors could be therapeutic
in SRDs (Morland et al., 2015; Shan et al., 2020). Interestingly,
a cAMP transcription factor, cAMP response element-binding
(CREB) protein, was implicated in PTSD, and can be inhibited
by dopamine blockers (Tsang and Lal, 1977; Martini et al., 2013;
Keil et al., 2016).
Another mitochondria-protective agent with therapeutic
potential in PTSD is dichloroacetate (DCA), a lactate inhibitor
with established anticancer and antiviral properties (Kho et al.,
2019). Despite these benefits, DCA use in PTSD is likely limited
by its serious adverse effects such as peripheral neuropathy and
delirium (Table 2).
Mitochondrial transplant, used with some success in pediatric
patients with Pearson’s syndrome, may also benefit PTSD patients
by replacing damaged organelles (Emani and McCully, 2018).
However, as of this time, it is unclear whether transplanted
mitochondria can survive in the extracellular environment or
selectively enter in the defective cells, indicating that this
intervention is not ready for clinical practice at this time.
However, another procedure based on introducing functional
mitochondria directly into dysfunctional cells may be more
promising for PTSD (Gomzikova et al., 2021).
Mitochondria and Neurosteroids
Neurosteroids, synthesized in the CNS, adrenals, and gonads, are
agonists at GABA-A receptors, that play a major role in regulating
multiple brain signaling pathways (Lightowlers et al., 2020).
Mitochondria initiate steroidogenesis by importing cholesterol
to synthesize pregnenolone, a precursor molecule, that exits the
organelle and is converted to progesterone, pregnanolone, and
allopregnanolone in the cytoplasm (Zorumski et al., 2013).
Women with PTSD demonstrated low CSF levels of
allopregnanolone and pregnanolone, further linking this
disorder to mitochondrial dysfunction (Rasmusson et al.,
2006; Almeida et al., 2021). Interestingly, allopregnanolone,
also known as brexanolone, was approved by the Food and
Drug Administration (FDA) for the treatment of postpartum
depression (Pineles et al., 2018; Morrison et al., 2019). Earlier
studies found that allopregnanolone improved the BBB
permeability, indicating potential benefits for senescent
endothelia and PTSD (brexanolone is currently in clinical trials
for this disorder) (NCT04468360). Moreover, allopregnanolone
was found therapeutic in PTSD and severe COVID-19, as it might
reverse some aspects of endothelial senescence (Lüscher and
Möhler, 2019). In addition, progesterone was reported beneficial
for both COVID-19 and PTSD, possibly by increasing NO in
cerebral ECs (Balan et al., 2019; Ney et al., 2019; Seligowski et al.,
2020). Indeed, as mentioned above, NO pathology contributes
to PTSD and is currently in clinical trials for COVID-19
(Ghandehari et al., 2021) (NCT04601077) (Table 2).
Taken together, neurosteroids may be therapeutic for PTSD
and COVID-19 as they improve mitochondrial function and
restore endothelial integrity.
Mitochondria and Bromodomains
The E (envelope) antigen of SARS-CoV-2 virus hijacks BRD2
and BRD4, possibly damaging mitochondria that in return trigger
cellular senescence, glycolytic states, and impaired antiviral
immunity (Gordon et al., 2020). In animal models, defective
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BRD4 was associated with impaired synaptic plasticity and
memory formation, likely linking this protein to PTSD-related
amnesia, depression, and anxiety, while at the same time
indicating that BRD4 inhibitors may be therapeutic for SRD
(Bruenig et al., 2017; Wang et al., 2021). The SARS-CoV-2 virus
may target BDR4 as it regulates antiviral immunity, including
the interferon-gamma (IFN-gamma), a molecule previously
associated with both PTSD and affective disorders (Bruenig et al.,
2018; Gibbons et al., 2019; Huang et al., 2021). Interestingly, in
humans, IFN-gamma was shown to drive EC senescence, linking
COVID-19 further to premature cellular aging (Bam et al., 2016).
Bromodomains are epigenetic readers that regulate the
chromatin landscape in cell nucleus, influencing multiple genes.
For example, BRD4 regulates the expression of mitochondrial
proteins encoded in nuclear DNA, including the ones in
charge of metabolism, suggesting that viral exploitation of this
protein may inhibit OXPHOS and activate glycolysis (Kim
et al., 2009, 2020). Indeed, BRD4 engenders the glycolytic
states associated with senescent cells and their secretome,
the senescence-associated secretory phenotype (SASP) (Barrow
et al., 2016). On the other hand, BRD4 inhibitors, including
JQ1 or SF2523, act as senolytics by promoting the clearance
of senescent and virus-infected cells (Tasdemir et al., 2016;
Go et al., 2021; Table 2). Moreover, as senolytics were
found therapeutic against idiopathic pulmonary fibrosis, a
BRD4-associated condition, these agents may be helpful to
SRD patients (Tang et al., 2013; Acharya et al., 2021). As
senolytic agents facilitate the clearance of all damaged cells,
including the malignant and virus-infected ones, they are
currently being evaluated for COVID-19 (Hu et al., 2020;
Go et al., 2021).
Taken together, this data links SRDs to dysfunctional
mitochondria and EC senescence, while, on the other hand,
BRD4 inhibitors protect the mitochondrion, preempting
premature endothelial aging.
Molecular Mimicry and Inflammation
Recent bioinformatic studies established that some SARS-
CoV-2 antigens mimic human proteins expressed by neurons,
astrocytes, and CECs, predisposing to PTSD. For example, viral
N protein shares amino acid residues with the human zonula
occludens-1 (ZO-1) and solute carrier family 12 member 6
(SLC12A6), molecules linked to BBB permeability (Hu et al.,
2020). In addition, tryptophan 5-hydroxylase 2 (TPH2), an
enzyme involved in serotonin synthesis, was found to have a
strong mimicry with the S protein of SARS-CoV-2, potentially
contributing to anxiety and depression (Yapici-Eser et al., 2021).
This is significant as TPH2 plays a major role in PTSD, as
well as in premature ECs senescence (Goçi Uka et al., 2019;
Wu, 2021). Moreover, the molecular mimicry between the
SARS-CoV-2 protein S and human anti-inflammatory proteins
was associated with inflammation, a pathology demonstrated
in PTSD (Kanduc, 2020). As mitochondrial damage can
directly activate inflammasomes, leading to inflammation, the
virus may utilize several mechanisms to ignite this pathology
(Zhou et al., 2011).
LIMITATIONS/GAPS/CHALLENGES
Epidemiologic studies have associated some viruses with anxiety,
depression, and PTSD however, only a handful of researchers
have systematically studied this connection. More studies are
needed to elucidate the interaction between communicable
diseases and psychiatric disorders, including SRDs. To fill the
knowledge gap between endothelia and PTSD, a combination
of different expertise domains is required, an endeavor often
difficult to accomplish in clinical context.
Despite these drawbacks, available studies appear to support
the concept that, like psychosocial trauma, some viruses promote
cellular senescence in many cell types, including ECs and
T cells, emphasizing the role of premature aging in these
conditions (Justice et al., 2019; Saleh et al., 2020). Indeed, trauma-
focused psychotherapy, was shown to restore the physiological
T cell phenotypes and reduce PTSD symptoms, suggesting
that psychotherapy may have a place in infectious diseases,
including the long COVID-19 (Prather et al., 2018). When this
is considered together with the fact that IFN-gamma, a regulator
of T cell aging, is depleted in both PTSD and COVID-19,
a bromodomain-mediated epigenetic mechanism is emerging
(Morath et al., 2014; De Biasi et al., 2020). Indeed, several studies
have pointed to the fact that in old brains’ T cells express
abundant IFN-gamma, a molecule that promotes BBB leakage
(Tewari et al., 2007; Michopoulos et al., 2017; Bonney et al.,
2019; Dulken et al., 2019). Although some studies failed to
demonstrate endothelial dysfunction in PTSD, they connected
this disorder to impaired coagulation, a pathology validated by
several other studies (von Känel et al., 2008; Robicsek et al., 2011).
Systematic studies in this area would be beneficial, especially
in the age that has seen increased incidence of viral infections
and SRDs.
CONCLUSION
COVID-19 has been associated with a high PTSD prevalence,
suggesting that aside from the psychological burden of the
disease itself, the virus may directly interfere with the stress-
processing brain areas. The virus-host interactome reveals
several pathogen-induced states, such as cellular senescence
and associated glycolysis, that facilitate viral replication, while
at the same time disrupt the BBB. The virus likely increases
PTSD susceptibility as, even in the absence of viral infection,
this disorder has been associated with EC senescence and
glycolytic states. This two-strike model not only may explain
the high comorbidity of COVID-19 and PTSD, but also opens
vistas for novel interventions, including ARBs, ACEi, ASIC1a
blockers, senolytics, furin inhibitors, BRD4 inhibitors and anti-
glycolytic interventions.
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J. B. D. N. F. (2018). A key factor with multipotent impact on brain signaling and
synaptic plasticity. Cell Mol. Neurobiol. 38, 579–593. doi: 10.1007/s10571-017-
0510-4
Krikov, M., Thone-Reineke, C., Müller, S., Villringer, A., and Unger, T. (2008).
Candesartan but not ramipril pretreatment improves outcome after stroke and
stimulates neurotrophin BNDF/TrkB system in rats. J. Hypertens. 26, 544–552.
doi: 10.1097/HJH.0b013e3282f2dac9
Krolow, R., Arcego, D. M., Noschang, C., Weis, S. N., and Dalmaz, C. (2014).
Oxidative imbalance and anxiety disorders. Curr. Neuropharmacol. 12, 193–
204. doi: 10.2174/1570159X11666131120223530
Krueger, K. E. (1995). Molecular and functional properties of mitochondrial
benzodiazepine receptors. Biochim. Biophys. Acta 1241, 453–470. doi: 10.1016/
0304-4157(95)00016-x
Kubera, B., Hubold, C., Otte, S., Lindenberg, A. S., Zeiss, I., Krause, R., et al. (2012).
Rise in plasma lactate concentrations with psychosocial stress: a possible sign of
cerebral energy demand. Obes. Facts 5, 384–392. doi: 10.1159/000339958
Kumar, A., and Chanana, P. (2017). Role of nitric oxide in stress-induced anxiety:
from pathophysiology to therapeutic target. Vitam. Horm. 103, 147–167. doi:
10.1016/bs.vh.2016.09.004
Kumar, S., Veldhuis, A., and Malhotra, T. (2021). Neuropsychiatric and cognitive
sequelae of COVID-19. Front. Psychol. 12:577529. doi: 10.3389/fpsyg.2021.
577529
Kunieda, T., Minamino, T., Nishi, J., Tateno, K., Oyama, T., Katsuno, T.,
et al. (2006). Angiotensin II induces premature senescence of vascular
smooth muscle cells and accelerates the development of atherosclerosis
via a p21-dependent pathway. Circulation 114, 953–960. doi: 10.1161/
CIRCULATIONAHA.106.626606
Kurihara, Y., Kurihara, H., Morita, H., Cao, W. H., Ling, G. Y., Kumada, M., et al.
(2000). Role of endothelin-1 in stress response in the central nervous system.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R515–R521. doi: 10.1152/
ajpregu.2000.279.2.R515
Lam, M. H. B., Wing, Y. K., Yu, M. W. M., Leung, C. M., Ma, R. C. W., Kong,
A. P. S., et al. (2009). Mental morbidities and chronic fatigue in severe acute
respiratory syndrome survivors long-term follow-up. Arch. Intern. Med. 169,
2142–2147.
Lancaster, C. L., Teeters, J. B., Gros, D. F., and Back, S. E. (2016). Posttraumatic
stress disorder: overview of evidence-based assessment and treatment. J. Clin.
Med. 5:105. doi: 10.3390/jcm5110105
Frontiers in Cellular Neuroscience | www.frontiersin.org 16 October 2021 | Volume 15 | Article 770387
fncel-15-770387 October 28, 2021 Time: 12:36 # 17
Sfera et al. COVID-19, PTSD, BBB
Leal, G., Afonso, P. M., Salazar, I. L., and Duarte, C. B. (2015). Regulation of
hippocampal synaptic plasticity by BDNF. Brain Res. 1621, 82–101. doi: 10.
1016/j.brainres.2014.10.019
Leung, S. W. S., and Shi, Y. (2021). The glycolytic process in endothelial cells and its
implications. Acta Pharmacol. Sin. [Epub ahead of print]. doi: 10.1038/s41401-
021-00647-y
Levin, E. G., Santell, L., and Osborn, K. G. (1997). The expression of endothelial
tissue plasminogen activator in vivo: a function defined by vessel size and
anatomic location. J. Cell Sci. 110(Pt 2), 139–148.
Lewis, R., Li, J., McCormick, P. J., L-H Huang, C., and Jeevaratnam, K. (2019). Is
the sigma-1 receptor a potential pharmacological target for cardiac pathologies?
A systematic review [published correction appears in Int J Cardiol Heart Vasc.
2020; 32:100700]. Int. J. Cardiol. Heart Vasc. 26:100449. doi: 10.1016/j.ijcha.
2019.100449
Li, D. P., and Pan, H. L. (2005). Angiotensin II attenuates synaptic GABA release
and excites paraventricular-rostral ventrolateral medulla output neurons.
J. Pharmacol. Exp. Ther. 313, 1035–1045. doi: 10.1124/jpet.104.082495
Li, Y., Li, L., Wu, J., Zhu, Z., Feng, X., Qin, L., et al. (2020). Activation of astrocytes
in hippocampus decreases fear memory through adenosine A1 receptors. eLife
9:e57155. doi: 10.7554/eLife.57155
Lightowlers, R. N., Chrzanowska-Lightowlers, Z. M., and Russell, O. M.
(2020). Mitochondrial transplantation-a possible therapeutic for mitochondrial
dysfunction?: mitochondrial transfer is a potential cure for many diseases but
proof of efficacy and safety is still lacking. EMBO Rep. 21:e50964. doi: 10.15252/
embr.202050964
Lin, L. H., Jin, J., Nashelsky, M. B., and Talman, W. T. (2014). Acid-sensing ion
channel 1 and nitric oxide synthase are in adjacent layers in the wall of rat and
human cerebral arteries. J. Chem. Neuroanat. 61-62, 161–168. doi: 10.1016/j.
jchemneu.2014.10.002
Lin, Y. J., Kwok, C. F., Juan, C. C., Hsu, Y. P., Shih, K. C., Chen, C. C.,
et al. (2014). Angiotensin II enhances endothelin-1-induced vasoconstriction
through upregulating endothelin type A receptor. Biochem. Biophys. Res.
Commun. 451, 263–269. doi: 10.1016/j.bbrc.2014.07.119
Liu, D. Y., Chi, T. Y., Ji, X. F., Liu, P., Qi, X. X., Zhu, L., et al. (2018).
Sigma-1 receptor activation alleviates blood-brain barrier dysfunction in
vascular dementia mice. Exp. Neurol. 308, 90–99. doi: 10.1016/j.expneurol.2018.
07.002
Liu, X. Y., Wei, B., Shi, H. X., Shan, Y. F., and Wang, C. (2010). Tom70 mediates
activation of interferon regulatory factor 3 on mitochondria. Cell Res. 20,
994–1011. doi: 10.1038/cr.2010.103
Luchkina, N. V., and Bolshakov, V. Y. (2019). Mechanisms of fear learning and
extinction: synaptic plasticity-fear memory connection. Psychopharmacology
236, 163–182. doi: 10.1007/s00213-018-5104-4
Lucido, C. T., Miskimins, W. K., and Vermeer, P. D. (2018). Propranolol promotes
glucose dependence and synergizes with dichloroacetate for anti-cancer activity
in HNSCC. Cancers 10:476. doi: 10.3390/cancers10120476
Lundgaard, I., Lu, M. L., Yang, E., Peng, W., Mestre, H., Hitomi, E., et al.
(2017). Glymphatic clearance controls state-dependent changes in brain lactate
concentration. J. Cereb. Blood Flow Metab. 37, 2112–2124. doi: 10.1177/
0271678X16661202
Lüscher, B., and Möhler, H. (2019). Brexanolone, a neurosteroid antidepressant,
vindicates the GABAergic deficit hypothesis of depression and may foster
resilience. F1000Research 8:F1000 Faculty Rev-751. doi: 10.12688/f1000
research.18758.1
Mader, S., and Brimberg, L. (2019). Aquaporin-4 water channel in the brain and its
implication for health and disease. Cells 8:90. doi: 10.3390/cells8020090
Mariajoseph-Antony, L. F., Kannan, A., Panneerselvam, A., Loganathan, C.,
Anbarasu, K., and Prahalathan, C. (2020). Could aquaporin modulators be
employed as prospective drugs for COVID-19 related pulmonary comorbidity?
Med. Hypotheses. 143:110201. doi: 10.1016/j.mehy.2020.110201
Marie, C., Pedard, M., Quirié, A., Tessier, A., Garnier, P., Totoson, P., et al. (2018).
Brain-derived neurotrophic factor secreted by the cerebral endothelium: a new
actor of brain function? J. Cereb. Blood Flow Metab. 38, 935–949. doi: 10.1177/
0271678X18766772
Marinzalda Mde, L., Pérez, P. A., Gargiulo, P. A., Casarsa, B. S., Bregonzio,
C., and Baiardi, G. (2014). Fear-potentiated behaviour is modulated by
central amygdala angiotensin II AT1 receptors stimulation. Biomed. Res. Int.
2014:183248. doi: 10.1155/2014/183248
Marriott, K. S., Prasad, M., Thapliyal, V., and Bose, H. S. (2012). σ-1 receptor at
the mitochondrial-associated endoplasmic reticulum membrane is responsible
for mitochondrial metabolic regulation. J. Pharmacol. Exp. Ther. 343, 578–586.
doi: 10.1124/jpet.112.198168
Martin-Fernandez, M., Jamison, S., Robin, L. M., Zhao, Z., Martin, E. D., Aguilar,
J., et al. (2017). Synapse-specific astrocyte gating of amygdala-related behavior.
Nat. Neurosci. 20, 1540–1548. doi: 10.1038/nn.4649
Martini, C., Da Pozzo, E., Carmassi, C., Cuboni, S., Trincavelli, M. L., Massimetti,
G., et al. (2013). Cyclic adenosine monophosphate responsive element binding
protein in post-traumatic stress disorder. World J. Biol. Psychiatry 14, 396–402.
doi: 10.3109/15622975.2011.577189
Martinotti, G., Sepede, G., Brunetti, M., Ricci, V., Gambi, F., Chillemi, E.,
et al. (2015). BDNF concentration and impulsiveness level in post-traumatic
stress disorder. Psychiatry Res. 229, 814–818. doi: 10.1016/j.psychres.2015.
07.085
Martinowich, K., Schloesser, R. J., Lu, Y., Jimenez, D. V., Paredes, D., Greene,
J. S., et al. (2012). Roles of p75(NTR), long-term depression, and cholinergic
transmission in anxiety and acute stress coping. Biol. Psychiatry 71, 75–83.
doi: 10.1016/j.biopsych.2011.08.014
Marvar, P. J., Goodman, J., Fuchs, S., Choi, D. C., Banerjee, S., and Ressler,
K. J. (2014). Angiotensin type 1 receptor inhibition enhances the extinction
of fear memory. Biol. Psychiatry 75, 864–872. doi: 10.1016/j.biopsych.2013.
08.024
Matsuoka, Y., Nishi, D., Tanima, Y., Itakura, M., Kojima, M., Hamazaki, K.,
et al. (2015). Serum pro-BDNF/BDNF as a treatment biomarker for response
to docosahexaenoic acid in traumatized people vulnerable to developing
psychological distress: a randomized controlled trial. Transl. Psychiatry 5:e596.
Matsushita, T., Isobe, N., Kawajiri, M., Mogi, M., Tsukuda, K., Horiuchi, M., et al.
(2010). CSF angiotensin II and angiotensin-converting enzyme levels in anti-
aquaporin-4 autoimmunity. J. Neurol Sci. 295, 41–45. doi: 10.1016/j.jns.2010.
05.014
McLay, R. N., and Ho, J. (2007). Posttraumatic stress disorder-like symptoms
after treatment with acetylcholinesterase inhibitors. J. Neuropsychiatry Clin.
Neurosci. 19, 92–93. doi: 10.1176/jnp.2007.19.1.92
Mehta, S. R., Iudicello, J. E., Lin, J., Ellis, R. J., Morgan, E., Okwuegbuna,
O., et al. (2021). Telomere length is associated with HIV infection,
methamphetamine use, inflammation, and comorbid disease risk. Drug Alcohol
Depend. 221:108639. doi: 10.1016/j.drugalcdep.2021.108639
Mellon, S. H., Bersani, F. S., Lindqvist, D., Hammamieh, R., Donohue, D., Dean,
K., et al. (2019). Metabolomic analysis of male combat veterans with post
traumatic stress disorder. PLoS One 14:e0213839. doi: 10.1371/journal.pone.
0213839
Meunier, J., and Hayashi, T. (2010). Sigma-1 receptors regulate Bcl-2 expression
by reactive oxygen species-dependent transcriptional regulation of nuclear
factor kappaB. J. Pharmacol. Exp. Ther. 332, 388–397. doi: 10.1124/jpet.109.
160960
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., and Jovanovic, T. (2017).
Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond.
Neuropsychopharmacology 42, 254–270. doi: 10.1038/npp.2016.146
Miller, J. K., McDougall, S., Thomas, S., and Wiener, J. (2017). The impact of
the brain-derived neurotrophic factor gene on trauma and spatial processing.
J. Clin. Med. 6:108. doi: 10.3390/jcm6120108
Miranda, M., Morici, J. F., Zanoni, M. B., and Bekinschtein, P. (2019). Brain-
derived neurotrophic factor: a key molecule for memory in the healthy and
the pathological brain. Front. Cell Neurosci. 13:363. doi: 10.3389/fncel.2019.
00363
Mohlenhoff, B. S., O’Donovan, A., Weiner, M. W., and Neylan, T. C. (2017).
Dementia risk in posttraumatic stress disorder: the relevance of sleep-related
abnormalities in brain structure, amyloid, and inflammation. Curr. Psychiatry
Rep. 19:89. doi: 10.1007/s11920-017-0835-1
Mojtabavi, H., Saghazadeh, A., van den Heuvel, L., Bucker, J., and Rezaei, N. (2020).
Peripheral blood levels of brain-derived neurotrophic factor in patients with
post-traumatic stress disorder (PTSD): a systematic review and meta-analysis.
PLoS One 15:e0241928. doi: 10.1371/journal.pone.0241928
Mongelli, A., Barbi, V., Gottardi Zamperla, M., Atlante, S., Forleo, L., Nesta, M.,
et al. (2021). Evidence for biological age acceleration and telomere shortening
in COVID-19 survivors. Int. J. Mol. Sci. 22:6151. doi: 10.3390/ijms221
16151
Frontiers in Cellular Neuroscience | www.frontiersin.org 17 October 2021 | Volume 15 | Article 770387
fncel-15-770387 October 28, 2021 Time: 12:36 # 18
Sfera et al. COVID-19, PTSD, BBB
Morais-de-Jesus, M., Daltro-Oliveira, R., Pettersen, K. M., Dantas-Duarte, A.,
Amaral, L. D., Cavalcanti-Ribeiro, P., et al. (2014). Hepatitis C virus infection
as a traumatic experience. PLoS One 9:e110529. doi: 10.1371/journal.pone.
0110529
Morath, J., Gola, H., Sommershof, A., Hamuni, G., Kolassa, S., Catani, C., et al.
(2014). The effect of trauma-focused therapy on the altered T cell distribution
in individuals with PTSD: evidence from a randomized controlled trial.
J. Psychiatr. Res. 54, 1–10. doi: 10.1016/j.jpsychires.2014.03.016
Morland, C., Andersson, K. A., Haugen, ØP., Hadzic, A., Kleppa, L., Gille,
A., et al. (2017). Exercise induces cerebral VEGF and angiogenesis via
the lactate receptor HCAR1. Nat. Commun. 8:15557. doi: 10.1038/ncomms
15557
Morland, C., Lauritzen, K. H., Puchades, M., Holm-Hansen, S., Andersson, K.,
Gjedde, A., et al. (2015). The lactate receptor, G-protein-coupled receptor
81/hydroxycarboxylic acid receptor 1: expression and action in brain.
J. Neurosci. Res. 93, 1045–1055. doi: 10.1002/jnr.23593
Morrison, K. E., Cole, A. B., Thompson, S. M., and Bale, T. L. (2019). Brexanolone
for the treatment of patients with postpartum depression. Drugs Today 55,
537–544. doi: 10.1358/dot.2019.55.9.3040864
Myers, K., and Davis, M. (2007). Mechanisms of fear extinction. Mol. Psychiatry 12,
120–150. doi: 10.1038/sj.mp.4001939
Nagelhus, E. A., and Ottersen, O. P. (2013). Physiological roles of aquaporin-
4 in brain. Physiol. Rev. 93, 1543–1562. doi: 10.1152/physrev.000
11.2013
Nakahashi, T., Fujimura, H., Altar, C. A., Li, J., Kambayashi, J., Tandon, N. N.,
et al. (2000). Vascular endothelial cells synthesize and secrete brain-derived
neurotrophic factor. FEBS Lett. 470, 113–117. doi: 10.1016/s0014-5793(00)
01302-8
Naoi, M., Maruyama, W., Akao, Y., Yi, H., and Yamaoka, Y. (2006). Involvement of
type A monoamine oxidase in neurodegeneration: regulation of mitochondrial
signaling leading to cell death or neuroprotection. J. Neural Transm. Suppl. 71,
67–77. doi: 10.1007/978-3-211-33328-0_8
Natsvlishvili, N., Goguadze, N., Zhuravliova, E., and Mikeladze, D. (2015). Sigma-1
receptor directly interacts with Rac1-GTPase in the brain mitochondria. BMC
Biochem. 16:11. doi: 10.1186/s12858-015-0040-y
Nehme, J., Borghesan, M., Mackedenski, S., Bird, T. G., and Demaria, M. (2020).
Cellular senescence as a potential mediator of COVID-19 severity in the elderly.
Aging Cell 19:e13237. doi: 10.1111/acel.13237
Neigh, G. N., Rhodes, S. T., Valdez, A., and Jovanovic, T. (2016). PTSD co-morbid
with HIV: separate but equal, or two parts of a whole? Neurobiol. Dis. 92(Pt B),
116–123. doi: 10.1016/j.nbd.2015.11.012
Ney, L. J., Gogos, A., Ken Hsu, C. M., and Felmingham, K. L. (2019). An alternative
theory for hormone effects on sex differences in PTSD: the role of heightened
sex hormones during trauma. Psychoneuroendocrinology 109:104416. doi: 10.
1016/j.psyneuen.2019.104416
Notaras, M., and van den Buuse, M. (2020). Neurobiology of BDNF in fear
memory, sensitivity to stress, and stress-related disorders. Mol. Psychiatry 25,
2251–2274. doi: 10.1038/s41380-019-0639-2
Owasil, R., O’Neill, R., Keable, A., Nimmo, J., MacGregor Sharp, M., Kelly, L.,
et al. (2020). The pattern of AQP4 expression in the ageing human brain
and in cerebral amyloid angiopathy. Int. J. Mol. Sci. 21:1225. doi: 10.3390/
ijms21041225
Padmakumar, S., Jones, G., Pawar, G., Khorkova, O., Hsiao, J., Kim, J., et al.
(2021). Minimally Invasive Nasal Depot (MIND) technique for direct BDNF
AntagoNAT delivery to the brain. J. Control Release 331, 176–186. doi: 10.1016/
j.jconrel.2021.01.027
Pal, A., Fontanilla, D., Gopalakrishnan, A., Chae, Y. K., Markley, J. L., and Ruoho,
A. E. (2012). The sigma-1 receptor protects against cellular oxidative stress
and activates antioxidant response elements. Eur. J. Pharmacol. 682, 12–20.
doi: 10.1016/j.ejphar.2012.01.030
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